Phensuximide: Difference between revisions
CSV import |
CSV import |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|An anticonvulsant medication}} | |||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002276 | |||
| IUPAC_name = 1-Methyl-3-phenylpyrrolidine-2,5-dione | |||
| image = Phensuximide.svg | |||
| image_size = 200px | |||
| image_alt = Structural formula of Phensuximide | |||
}} | |||
'''Phensuximide''' is a [[medication]] used primarily in the treatment of [[epilepsy]], specifically for [[absence seizures]]. It belongs to the class of [[succinimides]], which are known for their effectiveness in managing certain types of seizures. | |||
Phensuximide works by reducing | ==Pharmacology== | ||
Phensuximide works by reducing abnormal electrical activity in the brain. It is believed to modulate the activity of [[calcium channels]] in the [[thalamus]], a region of the brain that plays a key role in the generation of absence seizures. By stabilizing the neuronal activity, phensuximide helps to prevent the occurrence of seizures. | |||
== | ==Medical Uses== | ||
Phensuximide is primarily indicated for the control of absence seizures, also known as [[petit mal seizures]]. These seizures are characterized by brief, sudden lapses in attention and activity, often without any warning. Phensuximide is typically used when other medications, such as [[ethosuximide]], are not effective or cause unacceptable side effects. | |||
==Side Effects== | |||
Common side effects of phensuximide include [[gastrointestinal disturbances]] such as nausea and vomiting, as well as [[drowsiness]] and [[dizziness]]. In some cases, it may cause more serious side effects, including [[blood dyscrasias]] and [[liver toxicity]]. Patients taking phensuximide should be monitored regularly for any adverse effects. | |||
== | ==Mechanism of Action== | ||
[[File:Phensuximide.svg|thumb|right|Structural formula of Phensuximide]] | |||
Phensuximide's mechanism of action involves the inhibition of T-type calcium channels in the thalamic neurons. This inhibition reduces the pacemaker current that is responsible for generating the rhythmic cortical discharge associated with absence seizures. By dampening this activity, phensuximide helps to prevent the occurrence of seizures. | |||
Phensuximide | ==History== | ||
Phensuximide was developed as part of a series of succinimide derivatives aimed at improving the treatment of absence seizures. It was introduced as an alternative to other anticonvulsants with the goal of providing effective seizure control with fewer side effects. | |||
== | ==Related Compounds== | ||
Phensuximide is chemically related to other succinimide anticonvulsants, such as [[ethosuximide]] and [[methsuximide]]. These compounds share a similar mechanism of action and are used in the treatment of absence seizures. | |||
==Related Pages== | |||
* [[Epilepsy]] | * [[Epilepsy]] | ||
* [[ | * [[Anticonvulsant]] | ||
* [[ | * [[Calcium channel]] | ||
* [[Absence seizure]] | |||
[[ | |||
[[Category:Anticonvulsants]] | |||
[[Category:Succinimides]] | |||
[[Category:Epilepsy treatment]] | |||
Latest revision as of 11:39, 23 March 2025
An anticonvulsant medication
| Phensuximide | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Phensuximide is a medication used primarily in the treatment of epilepsy, specifically for absence seizures. It belongs to the class of succinimides, which are known for their effectiveness in managing certain types of seizures.
Pharmacology[edit]
Phensuximide works by reducing abnormal electrical activity in the brain. It is believed to modulate the activity of calcium channels in the thalamus, a region of the brain that plays a key role in the generation of absence seizures. By stabilizing the neuronal activity, phensuximide helps to prevent the occurrence of seizures.
Medical Uses[edit]
Phensuximide is primarily indicated for the control of absence seizures, also known as petit mal seizures. These seizures are characterized by brief, sudden lapses in attention and activity, often without any warning. Phensuximide is typically used when other medications, such as ethosuximide, are not effective or cause unacceptable side effects.
Side Effects[edit]
Common side effects of phensuximide include gastrointestinal disturbances such as nausea and vomiting, as well as drowsiness and dizziness. In some cases, it may cause more serious side effects, including blood dyscrasias and liver toxicity. Patients taking phensuximide should be monitored regularly for any adverse effects.
Mechanism of Action[edit]
Phensuximide's mechanism of action involves the inhibition of T-type calcium channels in the thalamic neurons. This inhibition reduces the pacemaker current that is responsible for generating the rhythmic cortical discharge associated with absence seizures. By dampening this activity, phensuximide helps to prevent the occurrence of seizures.
History[edit]
Phensuximide was developed as part of a series of succinimide derivatives aimed at improving the treatment of absence seizures. It was introduced as an alternative to other anticonvulsants with the goal of providing effective seizure control with fewer side effects.
Related Compounds[edit]
Phensuximide is chemically related to other succinimide anticonvulsants, such as ethosuximide and methsuximide. These compounds share a similar mechanism of action and are used in the treatment of absence seizures.
